info@srobf.cz +420 495 832 176
CZ / EN
O společnosti

TOP TEN ASTRO 2026

1. Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer 10-Year Outcomes from a Phase 3 Randomized Trial

2. Trial of Protons vs. Photons for Hepatocellular Carcinoma (HCC)

2. Initial Results of NRG Oncology NRG-GI003 A Phase III Randomized Trial of Protons vs. Photons for Hepatocellular Carcinoma (HCC)  PDF

3. Alliance A071801 Phase III Trial Postoperative Single Fraction Stereotactic Radiosurgery (SRS) vs. Fractionated SRS (fSRS) for Resected Brain Metastasis

4. NRG CC009 A Phase III Trial of Stereotactic Radiosurgery (SRS) vs. Hippocampal Avoidant Whole Brain Radiotherapy (HA WBRT) for Brain Metastases from Small Cell Lung Cancer (SCLC)

5. Efficacy of Radical Prostatectomy Versus Stereotactic Body Radiotherapy (SBRT) for Localised Prostate Cancer. Results from an international Phase III Randomised Controlled Trial (PACE - A)

6. SWOG S1827 MAVERICK A Randomized Phase III Trial of Brain MRI Surveillance with and without Prophylactic Cranial Irradiation (PCI) for SCLC

7. Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy NRG Oncology GU003

8. NRG-HN009 Randomized Phase IIIII Trial of RT + Cisplatin Q3 Weeks vs RT + Cisplatin Weekly for Patients with Locoregionally Advanced SCCHN p16-Negative Phase II Toxicity Results

9. Genomic Stratification of Benefit from Short-Term Androgen Deprivation with Dose-Escalated Radiotherapy in Intermediate-Risk Prostate Cancer An Ancillary Study of NRGRTOG 0815

10. TRIDENT Phase 3 Trial of Tumor Treating Fields (TTFields) Therapy Concurrent with Temozolomide (TMZ) Radiochemotherapy Followed by Maintenance TMZ and TTFields for Newly Diagnosed Glioblastoma (ndGBM)

1